Awesome quarter. May or may not matter to the stock price. The company continues to become more and more valuable and continues to perform wonderfully. The stock price on the other hand is it's own animal. This stock remains 30-50% below relative value of it's peers, yet continues to perform even better. Anything under $25 is basically a long term steal for the patient.
Yes it was considering the market conditions. I would expect their fracking sector to continue to see pricing pressures but at least their other xectors are holding up. Conference call tomorrow should add a little more info regarding next qtr and 2013. How much love wall street gives to the results will be interesting considering the performance of their peers lately.